India to Australia: Gefitinib Export Trade Route

The India to Australia Gefitinib corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $81.3K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's gefitinib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $27.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with gefitinib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 27.3%, placing it at rank #7 among India's top gefitinib export destinations globally.

On the import side, key buyers of Indian gefitinib in Australia include CIPLA AUSTRALIA PTY LIMITED, CIPLA AUSTRALIA PTY LTD,, CIPLA AUSTRALIA PTY LTD. CIPLA AUSTRALIA PTY LIMITED is the single largest importer with 1 shipments valued at $59.6K USD.

India's gefitinib exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $27.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as cipla gefitinib 250mg tablets (gefitinib 250 mg) (inv qty.225 pack x3x10's=6750 nos) and cipla gefitinib 250mg tablets (gefitinib 250 mg)(80 packs x3x10s= 2400 nos), suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CIPLA AUSTRALIA PTY LIMITED is the largest importer with 1 shipments worth $59.6K USD — representing 73% of all gefitinib imports from India on this route.